Medications

Merck, Eli Lilly probed on drug pricing

The Justice Department is probing some drug pricing practices of pharmaceutical giants Merck and Eli Lilly, the companies disclosed Friday in securities filings.

Cardiology

Study: Type 2 diabetes pill Jardiance cuts risk of death

Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to lengthen diabetics' lives.

Medications

British court ruling backs patent protecting Lilly's Alimta

Eli Lilly received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.

Medications

FDA warning: men's testosterone drugs overused (Update)

The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related issues ...

Oncology & Cancer

FDA: Cyramza approval now includes non-small-cell lung CA

(HealthDay)—U.S. Food and Drug Administration approval of the anti-cancer drug Cyramza (ramucirumab) has been expanded to include aggressive non-small-cell lung cancer (NSCLC), the agency said Friday.

page 8 from 12